Cargando…
Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investiga...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994851/ https://www.ncbi.nlm.nih.gov/pubmed/36705233 http://dx.doi.org/10.1097/MNM.0000000000001664 |
_version_ | 1784902704244457472 |
---|---|
author | Czibor, Sándor Carr, Robert Redondo, Francisca Auewarakul, Chirayu U. Cerci, Juliano J. Paez, Diana Fanti, Stefano Györke, Tamás |
author_facet | Czibor, Sándor Carr, Robert Redondo, Francisca Auewarakul, Chirayu U. Cerci, Juliano J. Paez, Diana Fanti, Stefano Györke, Tamás |
author_sort | Czibor, Sándor |
collection | PubMed |
description | 2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (ΔSUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. RESULTS: A total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different. Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, ΔSUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that ΔSUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). CONCLUSION: Baseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative ‘Deauville-like’ parameters performing best in the present study. |
format | Online Article Text |
id | pubmed-9994851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99948512023-03-09 Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients Czibor, Sándor Carr, Robert Redondo, Francisca Auewarakul, Chirayu U. Cerci, Juliano J. Paez, Diana Fanti, Stefano Györke, Tamás Nucl Med Commun Original Articles 2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (ΔSUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. RESULTS: A total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different. Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, ΔSUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that ΔSUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). CONCLUSION: Baseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative ‘Deauville-like’ parameters performing best in the present study. Lippincott Williams & Wilkins 2023-04 2023-01-30 /pmc/articles/PMC9994851/ /pubmed/36705233 http://dx.doi.org/10.1097/MNM.0000000000001664 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Czibor, Sándor Carr, Robert Redondo, Francisca Auewarakul, Chirayu U. Cerci, Juliano J. Paez, Diana Fanti, Stefano Györke, Tamás Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title | Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title_full | Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title_fullStr | Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title_full_unstemmed | Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title_short | Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients |
title_sort | prognostic parameters on baseline and interim [(18)f]fdg-pet/computed tomography in diffuse large b-cell lymphoma patients |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994851/ https://www.ncbi.nlm.nih.gov/pubmed/36705233 http://dx.doi.org/10.1097/MNM.0000000000001664 |
work_keys_str_mv | AT cziborsandor prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT carrrobert prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT redondofrancisca prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT auewarakulchirayuu prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT cercijulianoj prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT paezdiana prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT fantistefano prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients AT gyorketamas prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients |